首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Fortschritte der neurologie psychiatrie

缩写:FORTSCHR NEUROL PSYC

ISSN:0720-4299

e-ISSN:1439-3522

IF/分区:0.5/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1432
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Anastasia Theodoridou,Tri Kurniati Ambarini,Frauke Schultze-Lutter Anastasia Theodoridou
Three decades of research into early detection of and intervention in psychosis have produced specific risk criteria that indicate an average 300-fold increase in risk in the first step and allow for initial risk stratification using a comb...
Udo Bonnet,Norbert Scherbaum,Georg Juckel et al. Udo Bonnet et al.
Introduction: Esketamine nasal spray (EN) has been approved in Germany since 2021 for the treatment of treatment-resistant depression (TRD). Historically, the development of EN resulted from the positive results of random...
Jochen Mutschler,Ladina Pfyffer,Sebastian Fischer et al. Jochen Mutschler et al.
Aim of the study: Mental illnesses are on the rise both internationally and in Switzerland, pushing psychiatric care facilities to the limit of their capacity. As a result, there is a growing need for low-threshold psycho...
Franziska Abelein,Sophia Kabuya-Mulamba,Uwe Enders et al. Franziska Abelein et al.
Objectives: Emergency situations can lead to immediate admissions according to mental health act. It has never been investigated within the scope of the Bavarian Mental Health Act, which differences might be associated wi...
Maxim Maximov,Alberto Rodriguez Lago Maxim Maximov
Background: Neuromyelitis optica (NMO) and its related forms, collectively referred to as neuromyelitis optica spectrum disorders (NMOSD), are rare but often severe autoimmune diseases of the central nervous system (CNS)....
Maximilian Gahr,Karl Mischke,Michael Paulzen et al. Maximilian Gahr et al.
Background: The use of numerous psychotropic drugs is associated with a significant risk of cardiovascular adverse drug reactions (cvADR). Aim of the stud...
Cornelius Schüle,Anna Sobieraj,Helena Rogg Cornelius Schüle
Esketamine is an NMDA receptor antagonist and was approved as a nasal spray in March 2019, initially in the USA and then in December 2019 in Europe, as an adjunct to antidepressant pharmacotherapy for the treatment of treatment-resistant ma...
Lioba Grünfelder,Christiane Sandbote,Bernd Schönhofer et al. Lioba Grünfelder et al.
This case study illustrates the vulnerability of individuals with intellectual developmental disorders and autism spectrum disorders to crisis situations and severe, life-threatening complications that can arise from the loss of primary car...